Bayer decided to discontinue domestic supply of its antipyretic analgesic, ‘Bayer Aspirin 100mg.’ Despite the company’s explanation that the decision was made due to poor sales, the pharmacys’ eyes are not so kind on the company's decision as they have suffered shortages of stock issues regarding the product.

According to the Ministry of Food and Drug Safety on the 15th, Bayer has decided to discontinue the supply of its Bayer Aspirin 100mg tablet on the 31st of this month.

Bayer Korea explained, “We made the difficult decision to discontinue import of the product due to a decline in sales. We will discontinue supply with the last import of the product on December 29th last year."

Lee, Tak-Sun(hooggasi2@dailypharm.com)